Literature DB >> 22301190

A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH.

Hwa-Ryeon Kim1, Jae-Seok Roe, Ji-Eun Lee, In-Young Hwang, Eun-Jung Cho, Hong-Duk Youn.   

Abstract

p53 is a well-known transcription factor that controls cell cycle arrest and cell death in response to a wide range of stresses. Moreover, p53 regulates glucose metabolism and its mutation results in the metabolic switch to the Warburg effect found in cancer cells. Nucleotide biosynthesis is also critical for cell proliferation and the cell division cycle. Nonetheless, little is known about whether p53 regulates nucleotide biosynthesis. Here we demonstrated that p53-inducible microRNA-34a (miR-34a) repressed inosine 5'-monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme of de novo GTP biosynthesis. Treatment with anti-miR-34a inhibitor relieved the expression of IMPDH upon DNA damage. Ultimately, miR-34a-mediated inhibition of IMPDH resulted in repressed activation of the GTP-dependent Ras signaling pathway. In summary, we suggest that p53 has a novel function in regulating purine biosynthesis, aided by miR-34a-dependent IMPDH repression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301190     DOI: 10.1016/j.bbrc.2012.01.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  MicroRNAs in the pathobiology of sarcomas.

Authors:  Anne E Sarver; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 2.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

Review 3.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis.

Authors:  Chang Hui; Fu Yujie; Yuan Lijia; Yi Long; Xu Hongxia; Zhou Yong; Zhu Jundong; Zhang Qianyong; Mi Mantian
Journal:  Breast Cancer Res       Date:  2012-05-22       Impact factor: 6.466

5.  miR-34 - a microRNA replacement therapy is headed to the clinic.

Authors:  Andreas G Bader
Journal:  Front Genet       Date:  2012-07-02       Impact factor: 4.599

6.  The complexity of p53-mediated metabolic regulation in tumor suppression.

Authors:  Yanqing Liu; Wei Gu
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 17.012

7.  Tumor Protein p63/microRNA Network in Epithelial Cancer Cells.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

Review 8.  Mir-34: a new weapon against cancer?

Authors:  Gabriella Misso; Maria Teresa Di Martino; Giuseppe De Rosa; Ammad Ahmad Farooqi; Angela Lombardi; Virginia Campani; Mayra Rachele Zarone; Annamaria Gullà; Pierosandro Tagliaferri; Pierfrancesco Tassone; Michele Caraglia
Journal:  Mol Ther Nucleic Acids       Date:  2014-09-23       Impact factor: 10.183

9.  Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.

Authors:  Chi Han Li; Yangchao Chen
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

Review 10.  miR-34: from bench to bedside.

Authors:  Massimiliano Agostini; Richard A Knight
Journal:  Oncotarget       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.